Singapore-based HealthTech Start-Up Redefines Chronic Disease Care with Acquisition of Promising Clinic


HeartVoice, a joint venture between Omron Healthcare and iAPPS Pte Ltd, aims to prevent and eradicate chronic disease by transforming the traditional healthcare space.

SINGAPORE, 25 October 2021 / PRNewswire / – A HealthTech start-up, HeartVoice has announced the acquisition of Integrated Wellness Clinic in the Novena Specialist Center. The clinic has been offering health screening services for corporate clients since 2015, a pioneer in this field, having served more than 600 corporate clients and 45,000 patients. By combining its strong technological capabilities with the medical expertise of the clinic gained, HeartVoice has formed a new entity called i-Wellness @ HeartVoice to provide preventative healthcare solutions that go beyond prescribing drugs.

As a joint venture between OMRON Healthcare and iAPPS Pte Ltd., HeartVoice offers a comprehensive suite of MedTech solutions to help individuals and businesses achieve better health outcomes through preventive health services, powered by technology from digital transformation.

“Thanks to this acquisition, our team grew stronger with the addition of a medical branch made up of family physicians, trained nurses and sophisticated patient service agents (former SQ team leader to set customer service standards copies at the clinic). The entire HeartVoice team is now supported by a strong advisory board within the iAPPS Health group, led by its chairman, Dr Lam Pin Min, former senior minister of state for health, ”said Mr. Daisuke nozaki, Managing Director, HeartVoice Pte. Ltd.

Fighting chronic disease, one office at a time

HeartVoice redefined Solution for corporate clients involves individual and personalized care, where the journey of each patient begins with a company health examination. Based on individual results, employees will then be referred to diabetes or cardiology specialists from HeartVoice Medical Council or recommended to enroll in one of the health programs that concentrates on hypertension, Hyperlipidemia, Diabetes Where Obesity.

Each health program includes a remote patient monitoring module which is developed based on Omron’s monitoring dashboard and Bluetooth enabled medical devices. This allows patients to monitor their vital signs at home and share their readings directly with i-Wellness @ HeartVoice physicians for quick and frequent follow-ups.

To facilitate changes in patient behavior towards weight loss and diabetes control, HeartVoice offers nBuddy, a mobile lifestyle management application. Supported by clinical studies and scientific evidence and conceptualized by the Chief Dietitian of NUH, Dr. Lim Su Lin, nBuddy has been shown to be effective in promoting positive lifestyle changes, as reported in 4 peer-reviewed journals.

HeartVoice’s approach to healthcare is designed to guide patients through every step of their wellness journey, with all functionality integrated on a single platform for the convenience of both physician and patient.

To help other clinics in their digital transformation, HeartVoice was successful in securing financial assistance under the Infocomm Media Development Authority (IMDA) program for the PSG grant and the Skills Future Enterprise Credit (SFEC). To date, more than 30 general practitioners and specialty clinics have joined the HeartVoice network to provide telemedicine, remote patient monitoring and home monitoring services to their patients.

Serving the community in the time of Covid-19

In June 2021, the HeartVoice Clinic was nominated by that of Singapore Ministry of Health (“MOH”) as one of 31 private clinics to administer the Sinovac COVID-19 vaccine. Supported by a dedicated team with medical and technological knowledge, the clinic was able to administer complete doses of vaccination to more than 4,000 patients. Following its first vaccination campaign which ended in August, HeartVoice was also approved to provide Singapore residents with the pre-departure polymerase chain reaction (PCR) swab test and serologic antibody test for COVID-19.

As more expansion plans are underway, the HeartVoice team doesn’t plan on stopping anytime soon. From September 2021, the clinic has already started its second Sinovac vaccination campaign and was recently appointed by the Department of Health as one of the telemedicine providers for the home recovery program to help Singapore residents to recover safely from Covid-19 in the comfort from their homes.

On HeartVoice Pte Ltd

As a joint venture between OMRON Healthcare and iAPPS Pte Ltd., HeartVoice offers a comprehensive suite of MedTech solutions for healthcare providers, patients and businesses. By joining OMRON Healthcare on a mission to zero cardiac events, HeartVoice helps people achieve better health outcomes through preventive health care services.

In addition to video consultations and health screening, HeartVoice offers remote patient monitoring via a free app to record and monitor vital health signs. Patients can opt for a remote health program to better manage their ongoing chronic illnesses, synchronizing their health vital signs with their preferred doctor’s dashboard and receiving regular updates.

For more information:


Committed to improving people’s lives, OMRON Healthcare provides innovative and clinically proven medical equipment for health monitoring and therapy. Our product portfolio includes blood pressure monitors, nebulizers, electronic thermometers, transcutaneous electronic neurostimulators (TENS) as well as body composition monitors and professional medical devices. For many decades, OMRON devices have helped people prevent, treat and manage lifestyle-related illnesses both at home and in clinical practice in more than 100 countries around the world. The OMRON HEALTHCARE group is headquartered in Muko City, Kyoto prefecture, Japan.

For more information:

About iAPPS Pte. Ltd.

iAPPS is a pioneering financial technology company specializing in the development and marketing of mobile applications. Based at Singapore, it was awarded the Red Herring Top 100 Global 2014 and the Red Herring Top 100 Asia 2014. “ActiveSG”, launched in 2014, has remained the company’s largest product, with over 1.6 million users. . The app enables ‘ActiveSG’, a national sports initiative of the Singapore government.

For more information:

About the iAPPS Health Group

iAPPS Health Group is a quality-of-life, technology-driven Fin-MedTech company, powering a modern digital healthcare platform that delivers personalized, predictive and preventive 3P medicine through digital wallet features and Virtual health card, backed by data-driven innovation that organizes positive behavior changes and interventions in real time. With the vision to be the leading Fin-MedTech company providing the best health and wellness services in Singapore and beyond, the company’s mission is to enable individuals to live more abundantly thanks to 3P medicine activated by Fin-MedTech. iAPPS Health Group is a subsidiary of iAPPS Pte Ltd.

For more information on iAPPS Health Group, please visit

SOURCE HeartVoice Pte Ltd


Leave A Reply